Kevin Tang
10% Owner; Director; Director, Chief Executive Officer, 10% Owner · 3 filings · Latest: Jun 25, 2026
Aurinia Pharmaceuticals Inc.
Boundless Bio, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
BOLD | Kevin Tang | 10% Owner | Jun 29, 2026 | Purchase | $2.47 | 64,762 | $160.0K | 2,533,845 | |
BOLD | Kevin Tang | 10% Owner | Jun 26, 2026 | Purchase | $2.55 | 75,181 | $191.7K | 2,469,083 | |
BOLD | Kevin Tang | 10% Owner | Jun 25, 2026 | Purchase | $2.48 | 146,390 | $363.1K | 2,393,902 | |
AUPH | Kevin Tang | Director, Chief Executive Officer, 10% Owner | Jun 2, 2026 | Purchase | $15.28 | 206,005 | $3.1M | 13,044,106 | |
AUPH | Kevin Tang | Director, Chief Executive Officer, 10% Owner | Jun 1, 2026 | Purchase | $15.28 | 343,620 | $5.3M | 12,838,101 | |
AUPH | Kevin Tang | Director, Chief Executive Officer, 10% Owner | May 29, 2026 | Purchase | $15.31 | 264,981 | $4.1M | 12,494,481 | |
AUPH | Kevin Tang | Director | Mar 3, 2026 | Purchase | $14.22 | 184,208 | $2.6M | 12,229,500 | |
AUPH | Kevin Tang | Director | Mar 2, 2026 | Purchase | $14.26 | 199,353 | $2.8M | 12,045,292 | |
AUPH | Kevin Tang | Director | Feb 27, 2026 | Purchase | $13.99 | 516,439 | $7.2M | 11,845,939 |